OncoImmunology
Volume 10, 2021 - Issue 1
Open access
6,769
Views
29
CrossRef citations to date
0
Altmetric
Review
Trial watch: intratumoral immunotherapy
Juliette Humeaua Equipe labellisée par la Ligue contre le cancer, INSERM U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;c Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC H3C 3J7, Canada;d Department of Medicine, Université de Montréal, Montreal, Quebec H3C 3J7, Canadahttps://orcid.org/0000-0002-1991-8001View further author information
, Julie Le Naoura Equipe labellisée par la Ligue contre le cancer, INSERM U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;e Faculté de Médecine, Université Paris-Saclay, Kremlin Bicêtre, Francehttps://orcid.org/0000-0002-3749-2171View further author information
, Lorenzo Galluzzif Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA;g Sandra and Edward Meyer Cancer Center, New York, NY, USA;h Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA;i Department of Dermatology, Yale School of Medicine, New Haven, CT, USAhttps://orcid.org/0000-0003-2257-8500View further author information
, Guido Kroemera Equipe labellisée par la Ligue contre le cancer, INSERM U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;e Faculté de Médecine, Université Paris-Saclay, Kremlin Bicêtre, France;j Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;k Institut Universitaire de France, Paris, France;l Karolinska Institute, Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Sweden;m Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-9334-4405View further author information
& https://orcid.org/0000-0002-9334-4405View further author information
Jonathan G. Pola Equipe labellisée par la Ligue contre le cancer, INSERM U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France;b Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;e Faculté de Médecine, Université Paris-Saclay, Kremlin Bicêtre, Francehttps://orcid.org/0000-0002-8355-7562View further author information
Article: 1984677
|
Received 20 Sep 2021, Accepted 20 Sep 2021, Published online: 15 Oct 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.